New treatment option for subtype of aggressive lymphoma

A specific combination of mutations and new gene fusions have been discovered, that appear to be heavily implicated in tumor growth in patients with a particularly aggressive subtype of lymphoma (ALCL). The findings could lead to new targeted treatments for this disease and even to successful treatment of other types of cancer, the researchers say.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1E23eDj